BLTEBelite Bio, Inc
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Oversold (RSI 26). Price is −4% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Level with the previous count, down from 4.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BLTE is trading
Belite Bio, Inc is +120% over the past year while the S&P 500 is +18%: 101 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −4.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 26
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 20%
Below its 52-week high
Details›
- Last close2026-10-09
- $154.26
- 1 monthS&P 500 +2.7%
- −12%
- 1 yearS&P 500 +18%
- +120%
- vs 50-day average$165.55
- −6.8%
- 52-week high
- $193.66
- 52-week low
- $69.80
- Annualised volatility
- 54%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$2.9M
| Year | Return |
|---|---|
| 2026 (year to date) | −3.6% |
| 2025 | +154% |
| 2024 | +38% |
| 2023 | +52% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 1 of 4 | −2.1% |
| Feb | 4 | 3 of 4 | +7.1% |
| Mar | 4 | 1 of 4 | −6.8% |
| Apr | 4 | 1 of 4 | −1.2% |
| May | 5 | 3 of 5 | +3.3% |
| Jun | 5 | 2 of 5 | +16% |
| Jul | 5 | 5 of 5 | +19% |
| Aug | 5 | 1 of 5 | +7.7% |
| Sep | 5 | 3 of 5 | +4.2% |
| Oct | 5 | 3 of 5 | +16% |
| Nov | 4 | 3 of 4 | +12% |
| Dec | 4 | 2 of 4 | +4.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.